Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
Oral vancomycin and metronidazole, though they are the therapeutic choice for <i>Clostridioides difficile</i> infections (CDIs), also markedly disturb microbiota, leading to a prolonged loss of colonization resistance to <i>C. difficile</i> after therapy; as a result, their u...
Main Authors: | Chun-Wei Chiu, Pei-Jane Tsai, Ching-Chi Lee, Wen-Chien Ko, Yuan-Pin Hung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/6/649 |
Similar Items
-
Usefulness of Fecal Calprotectin in the Management of Patients with Toxigenic <i>Clostridioides difficile</i>
by: Cecilia Suarez-Carantoña, et al.
Published: (2021-04-01) -
Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
by: Alessandra Gazzola, et al.
Published: (2020-09-01) -
Gut Microbiota Composition Associated with <i>Clostridioides difficile</i> Colonization and Infection
by: Elisa Martinez, et al.
Published: (2022-07-01) -
High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
by: Katarina Curova, et al.
Published: (2023-03-01) -
Prevalence of Non-Toxigenic <i>Clostridioides difficile</i> in Diarrhoea Patients and Their Clinical Characteristics
by: Cheon-Hoo Jeon, et al.
Published: (2023-08-01)